...
首页> 外文期刊>BIOS >A preliminary analysis of the ability of standard DNA barcoding techniques to distinguish plant mixtures
【24h】

A preliminary analysis of the ability of standard DNA barcoding techniques to distinguish plant mixtures

机译:标准DNA条形码技术与区分植物混合物的能力初步分析

获取原文
获取原文并翻译 | 示例
           

摘要

The growing use of herbal medicines throughout the world has led to allegations of product adulteration, with potential deadly health risks for users. To prevent product adulteration, ingredients need to be verified, but traditional botanical identification techniques are inadequate as plant products are typically in processed forms (i.e. powder or tablet). DNA barcoding has been shown useful in verifying the components of herbal medicines; however, its accuracy in determining the ingredients of medicines with multiple plant species has not been experimentally evaluated. In theory, the use of standard DNA barcoding techniques should prove ineffective in the identification of the ingredients of mixed herbal medicines due to overlapping peaks in chromatograms which inhibit species resolution. The goal of this research is to evaluate the ability of standard DNA barcoding techniques to accurately determine the identity of species in mixed herbal medicine samples. DNA was isolated from five commonly used medicinal plant species. Fresh leaf tissue from four species was mixed at three different concentrations (25%, 50%, and 75%) with the target species (Ginkgo biloba) to create mixtures of known quantity and identity. Preliminary results show that DNA barcoding is able to determine the identity of herbal medicines containing one species but is unable to distinguish multiple species found in tested mixtures. Results may indicate that the composition of the mixed samples cannot be resolved, due in part to PCR bias caused by chloroplast copy number or secondary metabolites influencing PCR product production. As this study is one of the first to experimentally investigate standard DNA barcoding techniques for identifying species in mixed herbal medicines, more research needs to be conducted to address the issues highlighted here. In future studies, mixed samples should contain both broad and narrow phylogenetic dispersion and account for PCR bias among taxa to determine if sta
机译:在世界各地越来越多地使用草药导致产品掺假指控,为用户潜在致命的健康风险。为防止产品掺杂,需要验证成分,但传统的植物鉴定技术不充分,因为植物产品通常以加工形式(即粉末或片剂)。已显示DNA条形码可用于验证草药的组分;然而,它在确定具有多种植物物种的药物成分时的准确性尚未进行实验评估。理论上,使用标准DNA条形码技术的使用应在鉴定混合草药成分的鉴定中鉴定由于抑制物种分辨率的色谱图中的重叠峰来鉴定混合草药成分。本研究的目标是评估标准DNA条形码技术以准确确定混合草药样品中物种的身份的能力。从五种常用的药用植物物种中分离DNA。从四种物种的新鲜叶组织以三种不同的浓度(25%,50%和75%)混合,靶物种(银杏叶)形成已知数量和同一性的混合物。初步结果表明,DNA条形码能够确定含有一个物种但不能区分在经过测试的混合物中发现的多种物种的药草的身份。结果可能表明,由于影响PCR产物生产的叶绿体拷贝数或次级代谢物,因此不能分离混合样品的组成。由于本研究是首次进行实验研究标准DNA条形码技术的标准DNA条形码技术之一,用于鉴定混合草药中的物种,需要进行更多的研究以解决此处突出的问题。在未来的研究中,混合样品应含有宽且窄的系统发育分散性,并在分类群中占PCR偏倚,以确定STA

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号